Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PayMedix

Explore full profile

PayMedix is dedicated to solving the problem of high out-of-pocket costs for providers, patients, employers and TPAs

Milwaukee, United StatesFounded 2005Fintech
Valuation $100–250M Last recorded · 2026
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PayMedix and the history behind them.

About PayMedix

PayMedix operates as a financial technology platform designed to address the complexities and rising costs associated with healthcare payments in the United States. The company is a division of Health Payment Systems (HPS), a Milwaukee, Wisconsin-based organization founded in 2008. PayMedix itself began over a decade ago as the financing arm of HPS and has since evolved to offer its solutions nationwide, compatible with any PPO or HMO network. The firm is led by CEO Tom Policelli, who joined in February 2021. Policelli brings extensive experience from co-founding and leading other healthcare companies like Minuteman Health and Averde Health, and has held roles at United Health Group and CIGNA Healthcare.

The core of PayMedix's business is to simplify medical billing for patients and guarantee payments for healthcare providers. It serves a multi-sided market, including patients, medical providers (hospitals and physician practices), employers, and third-party administrators (TPAs). For patients, PayMedix consolidates what are often numerous and confusing medical bills and explanation of benefits (EOB) statements into a single, easy-to-understand monthly statement called the SuperEOB®. This approach simplifies expense management and provides clarity on healthcare costs. For providers, the platform eliminates financial risk and collection costs by guaranteeing prompt payment for all in-network patient out-of-pocket charges. PayMedix takes on the responsibility of collecting the patient balance, effectively removing bad debt from the provider's books.

The company's business model generates revenue primarily by charging fees to healthcare providers, who benefit from reduced billing complexities and the elimination of collection risks. A smaller portion of revenue comes from fees charged to employers. Notably, the service is structured to be consumer-friendly, as PayMedix does not charge interest or fees to patients, offering them guaranteed, zero-interest credit lines up to their out-of-pocket maximum, regardless of their credit history. This model of underwriting the employer group rather than the individual patient aims to improve health equity by ensuring all employees can access care without financial deterrence. The company has processed over $5 billion in medical payments and recently enhanced its capabilities by acquiring TempoPay, a healthcare payments solution.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
Milwaukee, United States
Open positions
4
Dealroom signal
23.7/100
Industry
Health, Fintech
Sub-industry
Mortgages & Lending
Sector
Fintech
Client focus
b2b, b2c
Investment activity
1 company, latest Aug 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Jan 2026 $17M — Escalate Capital Partners ↗
LATE VC✓Equity / VC Jan 2026 $16M $125M Escalate Capital Partners · RVM Enterprises Investment Group · SV Health Investors · HLM Venture Partners ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

PayMedix website traffic

Latest recorded traffic for PayMedix is 49K monthly website visits, up 345.5% over the last three months.

Latest monthly visits49K 3-month web change+345.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later8 investors entered at this stage

  • Caltius Capital Management
  • SVB Capital
  • Hexagon
  • Caltius Equity Partners
  • SV Health Investors
  • Escalate Capital Partners
  • HLM Venture Partners
  • RVM Enterprises Investment Group
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Milwaukee HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PayMedix on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PayMedix’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.